Literature DB >> 26718111

Drug therapy: Cetuximab or cisplatin in HNSCC?

Lisa Hutchinson.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26718111     DOI： 10.1038/nrclinonc.2015.235

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial.

Authors:  Stefano Maria Magrini; Michela Buglione; Renzo Corvò; Luigi Pirtoli; Fabiola Paiar; Pietro Ponticelli; Alessia Petrucci; Almalina Bacigalupo; Monica Crociani; Luciana Lastrucci; Stefania Vecchio; Pierluigi Bonomo; Nadia Pasinetti; Luca Triggiani; Roberta Cavagnini; Loredana Costa; Sandro Tonoli; Marta Maddalo; Salvatore Grisanti
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544
  1 in total
  1 in total

1.  Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts.

Authors:  Barbora Peltanova; Marketa Liskova; Jaromir Gumulec; Martina Raudenska; Hana Holcova Polanska; Tomas Vaculovic; David Kalfert; Marek Grega; Jan Plzak; Jan Betka; Michal Masarik
Journal:  Int J Mol Sci       Date:  2021-02-15       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.